iCAD announced it has signed a new strategic multi-year commercial agreement with Radiology Partners. Under the agreement, which was executed on June 27, Radiology Partners selected iCAD as its provider of breast AI technologies deployed through the Radiology Partners Cloud, allowing iCAD to leverage Radiology Partners’ clinical expertise, AI validation platform, scale, and leadership position to expand access to the Company’s Breast AI Suite to thousands of physicians and millions of patients. “We were pleased to join forces with Radiology Partners in November 2022, and the finalization of this commercial agreement marks a meaningful milestone in our collective mission to transform radiology by improving the workflow for providers and outcomes for patients,” said Dana Brown, President and CEO of iCAD, Inc.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on ICAD:
- iCAD Signs Strategic Commercial Agreement with Radiology Partners, the Nation’s Largest Radiology Practice
- iCAD’s “ProFound Insights, ProFound Impact” Webinar Series to Feature Cleveland Clinic
- iCAD announces ‘Profound Insights, ProFound Impact’ webinar event
- iCAD Offers ROI Analysis Based on Real-World Results from its ProFound Breast AI Suite at AHRA Annual Meeting
- iCAD showcases its ProFound AI Suite at AHRA 2023